Literature DB >> 6393607

The antibody response in Lyme disease.

J E Craft, R L Grodzicki, M Shrestha, D K Fischer, M García-Blanco, A C Steere.   

Abstract

We determined the antibody response against the Ixodes dammini spirochete in Lyme disease patients by indirect immunofluorescence and an enzyme-linked immunosorbent assay (ELISA). The specific IgM response became maximal three to six weeks after disease onset, and then declined, although titers sometimes remained elevated during later disease. Specific IgM levels correlated directly with total serum IgM. The specific IgG response, often delayed initially, was nearly always present during neuritis and arthritis, and frequently remained elevated after months of remission. Although results obtained by indirect immunofluorescence and the ELISA were similar, the ELISA was more sensitive and specific. Cross-reactive antibodies from patients with other spirochetal infections were blocked by absorption of sera with Borrelia hermsii, but titers of Lyme disease sera were also decreased. To further characterize the specificity of the humoral immune response against the I. dammini spirochete, 35S-methionine-labeled spirochetal antigens were identified by immunoprecipitation with sera from Lyme arthritis patients. These polypeptides had molecular weights of 62, 60, 47, 37, 22, 18, and 15 kDa, and were not recognized by control sera. We conclude that the ELISA, without absorption, is the best method to assay the humoral immune response in Lyme disease, and we have identified methionine-containing spirochetal polypeptides that may be important in Lyme arthritis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393607      PMCID: PMC2590019     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  11 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Neurologic abnormalities of Lyme disease.

Authors:  L Reik; A C Steere; N H Bartenhagen; R E Shope; S E Malawista
Journal:  Medicine (Baltimore)       Date:  1979-07       Impact factor: 1.889

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis.

Authors:  W E Deacon; J B Lucas; E V Price
Journal:  JAMA       Date:  1966-11-07       Impact factor: 56.272

6.  Cultivation of Borrelia hermsi.

Authors:  R Kelly
Journal:  Science       Date:  1971-07-30       Impact factor: 47.728

7.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

8.  Spirochetes isolated from the blood of two patients with Lyme disease.

Authors:  J L Benach; E M Bosler; J P Hanrahan; J L Coleman; G S Habicht; T F Bast; D J Cameron; J L Ziegler; A G Barbour; W Burgdorfer; R Edelman; R A Kaslow
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

9.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

10.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

View more
  14 in total

1.  An Update to a Review of Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease.

Authors:  Caterina M Miraglia
Journal:  J Chiropr Med       Date:  2020-12-15

2.  Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.

Authors:  M E Brandt; B S Riley; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi.

Authors:  Adriana R Marques; Ronald L Hornung; Len Dally; Mario T Philipp
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

4.  Comparison of seven commercial kits for detection of antibodies to Borrelia burgdorferi.

Authors:  J L Schmitz; C S Powell; J D Folds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

5.  Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1.

Authors:  Matthew B Lawrenz; R Mark Wooten; Steven J Norris
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  The amber theory of Lyme arthritis: initial description and clinical implications.

Authors:  Gary P Wormser; Robert B Nadelman; Ira Schwartz
Journal:  Clin Rheumatol       Date:  2012-03-13       Impact factor: 2.980

7.  Relapsing fever and its serological discrimination from Lyme borreliosis.

Authors:  P M Rath; G Rögler; A Schönberg; H D Pohle; F J Fehrenbach
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

8.  Chronic progressive neurological involvement in Borrelia burgdorferi infection.

Authors:  B Weder; P Wiedersheim; L Matter; A Steck; F Otto
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

9.  Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Authors:  Matthew B Lawrenz; R Mark Wooten; James F Zachary; Scott M Drouin; Janis J Weis; Rick A Wetsel; Steven J Norris
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Lymphocytic meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a clinical and serological study of 18 cases.

Authors:  C J Sindic; A Depre; G Bigaignon; P F Goubau; P Hella; C Laterre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.